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Although it is known that accumulation of oncogenic β-catenin is critical for intestinal
tumorigenesis, the underlying mechanisms have not yet been fully explored. Post-
translational β-catenin level is regulated via the adenomatous polyposis coli (APC)-
dependent as well as the APC-independent ubiquitin–proteasome pathway (UPP).
Employing an APC-mutant mouse model (APCMin/+) the present study aimed to investi-
gate the status of RXRα, an APC-independent factor involved in targeting β-catenin to
UPP for degradation, in tumor-bearing and tumor-free areas of intestine after exposure
to energetic 56Fe ions. APCMin/+ mice were exposed to energetic 56Fe ions (4 or 1.6Gy)
and intestinal tumor samples and tumor-free normal intestinal samples were collected
100–110days after exposure. The status of TCF4, β-catenin, cyclin D1, and RXRα
was examined using immunohistochemistry and immunoblots. We observed increased
accumulation of the transcription factor TCF4 and its co-activator β-catenin as well
as their downstream oncogenic target protein cyclin-D1 in 56Fe ion-induced intestinal
tumors. Further, decreased expression of RXRα in tumors as well as in adjacent normal
epithelium was indicative of perturbations in β-catenin proteasomal-targeting machinery.
This indicates that decreased UPP targeting of β-catenin due to downregulation of RXRα
can contribute to further accumulation of β-catenin and to 56Fe-induced tumorigenesis.
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Introduction
Heavy ion charged particle (HZE) radiation, such as 56Fe ions, is prevalent in deep space, and
is a major concern for astronauts’ health (1). Recently, using APCMin/+ mice, a well-accepted
mouse model for human colorectal cancer (CRC), we found increased risk of CRC development
accompanied by increased nuclear accumulation of oncogenic β-catenin and activation of its
downstream signaling after exposure to 56Fe ions (2–5). However, the mechanisms behind the
accumulation of oncogenic β-catenin are not yet fully understood.
Cellular levels of free β-catenin are tightly regulated via the ubiquitin–proteasome pathway
(UPP). Targeting of β-catenin to the proteasome and its subsequent degradation involves two adeno-
matous polyposis coli (APC)-dependent (i.e., APC/GSK3β/AXIN and APC/Siah1) and one APC-
independent (RXRα-mediated) mechanisms (6). In gastrointestinal (GI) tumors, genes involved
in APC-dependent (APC, Siah1, and Axin) targeting of β-catenin are often mutated (7–11), and
similarly in APCMin/+ mice, tumor formation is mostly driven through inactivation of the wild type
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APC allele (12). Thus, APC-dependent proteasomal targeting of
β-catenin is eventually disabled in these tumors. In the absence
of proteasomal targeting, β-catenin accumulates and interacts
with T-cell factor transcription factors (TCF4) in the nucleus
leading to activation of oncogenic signaling pathways (13). In
view of the known perturbations in APC-dependent proteasomal
targeting of β-catenin early in the GI tumorigenesis process, only
theAPC-independent (RXRα-dependent) pathwaywould remain
to control its accumulation. However, the status of the APC-
independent proteasomal targeting of the β-catenin in heavy ion
radiation-induced intestinal tumors has not been explored. In this
study, using the APCMin/+ intestinal tumor mouse model (14), we
demonstrated downregulation of RXRα expression, which may
complement the disabled APC-dependent proteasomal degrada-
tion pathway to increase β-catenin accumulation in 56Fe-induced
tumors. Downregulation of RXRα observed in this study could
potentially play a crucial role in heavy ion radiation-induced
increased risk of intestinal tumorigenesis and would warrant
further investigation.
Materials and Methods
Mice and Genotyping
Male APCMin/+ mice (The Jackson Laboratory, Bar Harbor, ME,
USA) were bred with female C57BL/6J mice at the Georgetown
University (GU)’s animal facility. Genotyping using tail DNA
samples were done using reverse-transcription polymerase chain
reaction (RT-PCR) to identify heterozygous offspring as per the
Jackson Laboratory protocol. The mouse colony was maintained
on standard certified rodent diet and filtered water in a humidity
and temperature-controlled room with 12 h dark/light cycle. All
experimental procedures were performed in compliance with the
protocols approved by the Institutional Animal Care and Use
Committee (IACUC) at GU and Brookhaven National Labora-
tory (BNL). Both the facilities are Association for Assessment
and Accreditation of Laboratory and Animal Care International
(AAALACI) accredited facilities and we followed The Guide for
the Care and Use of Laboratory Animals.
Irradiation and Sample Collection
APCMin/+ female mice (6–8-weeks old) were placed in well-
ventilated transparent plastic boxes (1mouse/box) allowing easy
movement and irradiated with 4 or 1.6Gy whole body 56Fe
radiation (energy: 1000MeV/n; LET: 148 keV/μm; dose rate:
1Gy/min) at the NASA Space Radiation Laboratory (NSRL) at
BNL. These two doses were used in our previously published
tumorigenesis experiments and samples collected during that
study were used for molecular analysis in this study. For 56Fe
exposure, both control and treatment groups were shipped to
BNL for irradiation and brought back to GU after irradiation
in a temperature-controlled vehicle for a same day delivery to
minimize stress to the animals. Age-matched 56Fe-irradiated and
control mice were euthanized by CO2 asphyxiation between 100
and 110 days after radiation exposure. The small intestinal tract
was surgically removed, washed with phosphate-buffered saline
(PBS), and cut open longitudinally at room temperature. A dis-
secting scope (Leica MZ6, Buffalo Grove, IL, USA) was used
to visualize and dissect tumors, which were then flash frozen
in liquid nitrogen and stored at  80°C for further use. Also,
intestinal samples (~3 cm) with tumor-bearing and surrounding
tumor-free area were fixed overnight in 10% buffered formalin,
embedded in paraffin, and 4μm-thick sections were obtained for
immunohistochemistry staining.
Immunohistochemistry
Intestinal sections (n= 5 mice per group) were used for immuno-
histochemistry with a protocol described earlier (3). Briefly,
immunostaining for active-β-catenin (Cat#05-665, Millipore, Bil-
lerica, MA, USA; dilution: 1:100), TCF4 (Cat#05-511, Millipore;
dilution: 1:100), RXRα (Cat#sc-553, Santa Cruz Biotechnology,
Dallas, TX, USA; dilution: 1:40), and cyclin D1 (Cat#04-1151;
Millipore; dilution: 1:150) were performed by soaking slides in
antigen retrieval citrate buffer (pH 6.0; Dako, Carpinteria, CA,
USA) and heating at 100°C for 15min in a microwave oven.
Further, endogenous peroxidase activity was quenched using 3%
hydrogen peroxide in methanol followed by incubation in block-
ing buffer (5% bovine serum albumin in PBS) for 30min. After
blocking sectionswere incubated overnight at 4°Cwith the respec-
tive primary antibody. Signal detection and color development
was done using SuperPicture 3rd Gen IHC detection kit (Cat#87-
9673; Invitrogen, Carlsbad, CA, USA). Sections were counter-
stained using hematoxylin and images were acquired using bright
field microscopy at a magnification of 20. At least 10 randomly
chosen images from the tumor-bearing as well as from the tumor-
free areas were acquired from each mouse and a representative
image from each group is shown in the results. Images were ana-
lyzed using color deconvolution and image-based tool for count-
ing nuclei (ITCN) plug-ins of ImageJ v1.45 software (National
Institutes of Health, Bethesda, MD, USA). Quantification data
were statistically analyzed using two-tailed paired Student’s t-test
and difference between control and irradiated group was con-
sidered significant when p-value was <0.05. Error bars represent
mean SEM.
Immunoblots
Frozen intestinal tumor samples (n= 5 mice per group) were
pooled and used for immunoblot analysis of RXRα level with a
protocol described previously (3). Briefly, samples were homog-
enized in ice-cold lysis buffer, centrifuged, and supernatant col-
lected. Protein was estimated in supernatant and equal amount
of protein was used for sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE). Protein was transferred to PVDF
membrane, incubated with RXRα antibody, and protein detected
using horseradish peroxidase (HRP) conjugated secondary anti-
body and enhanced chemiluminescence (ECL) detection system
(Cat# 34080, Thermo Fisher Scientific, Rockford, IL, USA) and
representative images shown in the results.
Results
Increased β-Catenin and TCF4 Levels in
56Fe-Induced Intestinal Tumor
Intestinal tumors stained for β-catenin showed increased level
in 4Gy 56Fe-irradiated samples relative to control tumors from
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sham-irradiated mice (Figures 1A,B) and this is consistent with
our previous results after 1.6Gy 56Fe irradiation (3). Higher
levels were also observed for TCF4 in 56Fe-irradiated intestinal
tumors relative to controls (Figures 1C,D). Transcription factor
TCF4 along with the transcriptional co-activator β-catenin are
involved in transcribing pro-proliferative factors, such as cyclin
D1, and increased cyclin D1 was observed in the current study
(Figures 1E,F) as well.
Reduced Expression of RXRα in Tumor-Bearing
and Tumor-Free Areas of APCMin/+Mice After
Exposure to 56Fe Radiation
Immunohistochemistry in tumor samples demonstrated that
expression of RXRα was reduced after 4Gy (Figure 2A). Quan-
tification and statistical analysis of stained sections from five mice
showed that RXRα was significantly lowered in 56Fe-irradiated
tumors relative to sham-irradiated tumors (Figure 2B). Intestinal
tumors from 1.6Gy 56Fe-irradiated mice also showed decreased
RXRα staining (Figure 2C) and quantification and statistical
analysis showed that the staining in irradiated sampleswere signif-
icantly lower compared to controls (Figure 2D). However, quan-
tification did not show significant difference in RXRα staining
between two radiation doses. Immunoblots of 4Gy (Figure 2E)
and 1.6Gy (Figure 2F) intestinal tumor samples also showed
decreased RXRα. We also performed immunohistochemistry for
RXRα on tumor-free intestinal sections from APCMin/+ mice
exposed to either 1.6 or 4Gy 56Fe ions. Staining of tumor-free
intestinal section showed lower expression of RXRα after 4Gy
56Fe relative to corresponding controls (Figure 3A). Decreased
RXRα after 4Gy 56Fe was statistically significant compared
to sham-irradiated controls (Figure 3B). Conversely, we also
observed downregulation of RXRα in 1.6Gy irradiated samples
FIGURE 1 | Accumulation and activation of oncogenic β-catenin signaling in 56Fe-induced intestinal tumors compared to spontaneous tumors from
sham-irradiated mice (control). (A) Immunohistochemical detection of active-β-catenin in 56Fe-induced intestinal tumors. (B) Quantification of β-catenin
expression in intestinal tumors. (C) Immunohistochemical detection of β-catenin transcriptional regulator TCF4 in 56Fe-induced intestinal tumors. (D) Quantification of
TCF4 positive nuclei in intestinal tumors. (E) Immunohistochemical detection of β-catenin/TCF4 oncogenic target cyclin-D1 in 56Fe-induced intestinal tumors.
(F) Quantification of cyclin-D1 positive nuclei in intestinal tumors. Error bars represent meanSEM and p<0.05 was considered significant. AU – Arbitrary Unit.
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FIGURE 2 | Lower RXRα expression in 56Fe-induced intestinal tumors. (A) Representative immunohistochemistry images showing expression of RXRα in
spontaneous and 4Gy 56Fe-induced intestinal tumors. (B) Quantification of RXRα in spontaneous and 4Gy 56Fe-induced intestinal tumors. (C) Expression of RXRα
in spontaneous and 1.6Gy 56Fe-induced intestinal tumors. (D) Quantification of RXRα in spontaneous and 1.6Gy 56Fe-induced intestinal tumors. (E) Immunoblots of
RXRα in spontaneous and 4Gy 56Fe-induced intestinal tumors. (F) Immunoblots of RXRα in spontaneous and 1.6Gy 56Fe-induced intestinal tumors. Error bars
represent meanSEM and p<0.05 was considered significant.
compared to controls (Figure 3C) and quantification showed
statistically significant difference between irradiated and sham-
irradiated samples (Figure 3D).
Discussion
The carcinogenic potential of ionizing radiation is well known
and using animal models it has been established that high-
LET heavy ion radiation has higher carcinogenic potential com-
pared to low-LET radiation (15). Increased frequencies of site-
specific cancer following heavy ion exposure have been reported
in various rodent models with upregulation of oncogenic sig-
naling mediated through genetic, epigenetic, and/or physiolog-
ical changes (3, 15–17). Earlier studies conducted in APCMin/+
mice revealed increased tumor induction and a higher number
of adenocarcinomas, which was associated with greater upreg-
ulation of β-catenin signaling after 56Fe exposure relative to γ
radiation; this is indicative of perturbations in the molecular
events upstreamof β-catenin (3). The purpose of the current study
was to develop mechanistic insight into greater tumorigenesis
observed in our previous work in APCMin/+ mice after two doses
of 56Fe radiation relative to γ radiation. While pathways can be
investigated in the wild-type mice, they are resistant to intestinal
tumorigenesis. Therefore, we used APC-mutant mice not only
to quantitatively assess tumor frequency but also to understand
molecular pathway alterations, which may have contributed to
tumor development after radiation exposure. While we reported
previously that two doses of 56Fe caused higher tumor frequency,
we are yet to fully understand molecular characteristics of the
tumors and tumor-adjacent normal tissues after 56Fe irradiation.
To this end, the results presented in the current study explain in
part potential underlying mechanisms contributing to increased
tumor frequency after 56Fe irradiation. We have focused on the
APC-independent mechanism of β-catenin degradation via UPP.
InAPC-deficient adenoma, accumulation of β-catenin complexed
with nuclear TCF4 results in the increased expression of its onco-
genic target genes, such as cyclin-D1 that promotes intestinal
cell proliferation and polyp formation (18). In agreement with
our published reports in APCMin/+ mice exposed to 1.6Gy of
56Fe ion, the current study also observed similar activation of
β-catenin at 4Gy of 56Fe ion along with increased TCF4 and
cyclin-D1. Significant loss of RXRα was evident in tumors as well
as in tumor-free areas of intestine after 56Fe radiation and this
could contribute to decreased proteasomal targeting of β-catenin,
therefore enhancing cell survival and proliferation through β-
catenin/TCF4 signaling. Notably, RXRα was downregulated in
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FIGURE 3 | Downregulation of RXRα was observed in tumor-free areas of intestinal samples from APCMin/+ mice. (A) Decreased RXRα expression after
4Gy 56Fe radiation. (B) Quantification of immunohistochemistry images showed significant decrease in RXRα after 4Gy 56Fe. (C) Decreased RXRα expression after
1.6Gy 56Fe radiation. (D) Quantification of immunohistochemistry images showed significant decrease in RXRα after 1.6Gy 56Fe. Error bars represent meanSEM
and p<0.05 was considered significant.
both the radiation doses tested suggesting that the effect is inde-
pendent of radiation dose and that the lower dose may have a
proportionately greater effect relative to the higher dose. We rec-
ognize that themean absorbed doses of energetic 56Fe ions used in
the current study are higher than the doses astronauts are expected
to receive during prolonged space missions. These high doses of
energetic 56Fe ions were used as a proof of principle in our initial
studies for establishing the differential effects, quantitatively and
qualitatively, of space compared to γ radiation.
Loss of the remaining wild type APC allele has often been
implicated as the primary mechanism for increased β-catenin
signaling leading to tumor development in APCMin/+ mice (12,
19, 20). In addition to APC, the β-catenin cellular level is also
regulated through a direct proteasomal targeting mediated by
RXRα (21) and downregulation of RXRα in human and rodent
colonic tumors has been reported previously (22). Considering
that protein turnover is critical for cellular homeostasis, avail-
ability of multiple independent pathways for protein degrada-
tion ensures that the potentially pro-carcinogenic β-catenin level
remains within physiologic limits to limit cancer initiation and
progression. Downregulation of RXRα in our model system may
have played a role in 56Fe radiation-induced more aggressive
tumorigenesis reported earlier (3). Apart from driving proteaso-
mal degradation of β-catenin, RXRα also functions to suppress
β-catenin-mediated upregulation of oncogenes through direct
protein–protein interaction (23) in colon cancer cells. Thus, loss
of RXRα expression could further stabilize β-catenin signaling in
tumor cells, leading to greater cell proliferation and higher num-
ber of invasive cancers associated with 56Fe relative to γ radiation.
Nuclear receptor RXRα is known to heterodimerize with a
host of other nuclear receptors, such as the vitamin D receptor
(VDR) and retinoid acid receptor (RAR), and is involved through
transactivation of target genes, such as p21, in regulating normal
growth and development (23, 24). Consequently, loss of RXRα
is expected to cause disordered cellular proliferation, and indeed,
downregulation of RXRα has been widely reported in a number
of cancers including CRC (21–26). Our result demonstrates for
the first time that RXRα is downregulated in tumor-free areas
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FIGURE 4 | Schematic representation of APC-dependent and
APC-independent pathways of UPP involved in β-catenin degradation
in APCMin/+ mice.
of APCMin/+ intestine ~100 days after radiation exposure. Con-
sidering that a significant number of intestinal adenomas has
also been reported to arise without the loss of heterozygosity
of the APC gene and these adenomas are often polyclonal (8,
20, 27), our results supports an APC-independent mechanism of
β-catenin stabilization during 56Fe-irradiated tumorigenesis. We
believe that decreased RXRα expression in tumor-free areas of
the intestine may be a reflection of the RXRα status in other
areas of the GI tract and that this molecular event may be pre-
ceding intestinal tumorigenesis in APCMin/+ mice. Furthermore,
RXRα signaling is also linked to cellular redox regulation and it
has been demonstrated that RXRα activation protects cell from
oxidative stress and inhibition promotes ROS production (28, 29).
Downregulation of RXRα observed ~100 days post-exposure in
the current study aligns with our previous studies demonstrating
chronic oxidative stress even 1 year after exposure to energetic
56Fe ions (30). Although we observed persistent oxidative stress
after γ radiation, it was less pronounced relative to equitoxic doses
of 56Fe radiation. Additionally, intestinal tumor frequency and
grade was also higher after 56Fe relative to equitoxic doses of
γ radiation. Considering that γ radiation responses were consis-
tently lower relative to 56Fe, in the current study, we have analyzed
and presented 56Fe-induced alterations of an alternate pathway
involved in β-catenin regulation via RXRα. Our data, previous
and current, demonstrate that effects of radiation on redox bal-
ance, carcinogenesis, and related molecular pathways are depen-
dent on radiation quality and energy deposition characteristics.
However, further in depth studies will be required to dissect the
link between heavy ion radiation exposure and long-termmolecu-
lar alterations, such as oxidative stress and RXRα downregulation.
In summary, our results show that energetic heavy ion radiation
is capable of lowering RXRα in tumor as well as non-tumor
intestinal epithelial cells. Due to its roles in multiple cellular pro-
cesses, continuous downregulation of RXRα, we believe, will have
major ramifications for intestinal cellular homeostasis with impli-
cations for carcinogenesis including colorectal carcinogenesis
(Figure 4).
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